BSEBoard Meeting5d ago · 25 Aug 2026, 04:50 pm

Outcome of Board Meeting held on 25th August, 2026

Bacil Pharma Ltd · 524516

✦ AI SummaryMgmt Change

Bacil Pharma Ltd's Board of Directors approved the appointment of two new directors, Mr. Mahesh Singh and Mr. Anil Shiv Charan Singh, as non-executive independent directors, subject to member approval.

Analysis Scores

Earnings Impact2/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bacil Pharma Ltd - 524516 - Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th August, 2026

Attachments (1)

📄

45264bd6-be73-4f4f-a9e2-0e202db4d2ef.pdf

pdf

Download →
View document text
Reg Office: G2 & G3 Samarpan Complex, Next to Mirador Hotel, Chakala, Andheri East, Mumbai – 400099 Email Id: bacilpha@yahoo.com, CIN: L24200MH1987PLC043427, Tel: 22618452/22661541, Tel/Fax: 22618327 Date: 25th August, 2026 The Listing Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001 Scrip Code: 524516 | Scrip ID: BACPHAR Subject: Outcome of Board Meeting held on 25th August, 2026 Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of Bacil Pharma Limited, at its meeting held on Tuesday, 25th August, 2026, inter alia, considered and approved the following matters: 1. Appointment of Mr. Mahesh Singh as Non-Executive Independent Director The Board approved the appointment of Mr. Mahesh Singh (DIN: 11814569) as an Additional Director in the capacity of Non-Executive Independent Director of the Company, subject to the approval of the Members, wherever applicable. 2. Appointment of Mr. Anil Shiv Charan Singh as Non-Executive Director The Board approved the appointment of Mr. Anil Shiv Charan Singh (DIN: 09338444) as an Additional Director in the capacity of Non-Executive Director of the Company, subject to the approval of the Members, wherever applicable. Both the above Directors have submitted the necessary declarations and confirmations as required under the applicable provisions of the Companies Act, 2013 and SEBI LODR Regulations. Further, the above Directors are not debarred from holding the office of Director by virtue of any order of SEBI or any other regulatory authority. The detailed disclosures as required under Regulation 30 of the SEBI LODR Regulations read with the applicable SEBI Circular are enclosed as Annexure A. The meeting commenced at 3:30 P.M. and concluded at 4:30 P.M. Kindly take the above information on record. Thanking You, For BACIL PHARMA LIMITED Ms. Chaitali Kalpataru Shah Director & CFO DIN: 11167778 Reg Office: G2 & G3 Samarpan Complex, Next to Mirador Hotel, Chakala, Andheri East, Mumbai – 400099 Email Id: bacilpha@yahoo.com, CIN: L24200MH1987PLC043427, Tel: 22618452/22661541, Tel/Fax: 22618327 Annexure A Details of Directors Appointed Particulars Mr. Mahesh Singh Mr. Anil Shiv Charan Singh Name Mr. Mahesh Singh Mr. Anil Shiv Charan Singh Designation Additional Director – Additional Director – Non- Independent Director Executive Director Date of 25th August, 2026 25th August, 2026 Appointment Term Subject to approval of Subject to approval of Members Members Brief Profile Mr. Mahesh Singh is a Mr. Anil Shiv Charan Singh has professional in the trading experience in business industry with over seven management and commercial years of experience in product activities and possesses sales, brand establishment and knowledge of business business development. He operations and management. His possesses expertise in online experience and business acumen sales strategies and are expected to contribute to the marketplace expansion and Company’s strategic decision- has successfully contributed to making and business business growth across development. diverse product categories. Disclosure of Not related to any Director of Not related to any Director of the relationships the Company Company between Directors Debarment Not debarred from holding the Not debarred from holding the office of Director by virtue of office of Director by virtue of any any SEBI order or any other SEBI order or any other authority authority Reason for To strengthen the Board with To strengthen the Board with Appointment experience in accounting and experience in commodity trading financial matters and related business activities